临床外科杂志 ›› 2022, Vol. 30 ›› Issue (1): 40-43.doi: 10.3969/j.issn.1005-6483.2022.01.013

• 论著 • 上一篇    下一篇

伴桥本甲状腺炎的甲状腺乳头状癌临床病理特征及其手术策略

  

  1. 210029 南京中医药大学附属医院普外科
  • 出版日期:2022-01-20 发布日期:2022-01-20
  • 通讯作者: 王高元,Email:Wangg-Y@163.com

Clinicopathological features and surgical strategy of papillary thyroid carcinoma with coexistent Hashimoto’s thyroiditis

  1. Department of General Surgery,Affiliated Hospital of Nanjing University of Chinese Medicine,Nanjing 210029, China
  • Online:2022-01-20 Published:2022-01-20

摘要: 目的  探讨伴桥本甲状腺炎(HT)的甲状腺乳头状癌(PTC)的临床病理特征及手术策略。
方法  2016年7月~2020年12月我院收治的PTC病人884例,比较伴HT和不伴HT的PTC病人的临床病理特征;分析伴HT的PTC病人发生中央区淋巴结转移的危险因素。
结果  伴HT的PTC病人占总PTC病人的30.8%。与不伴HT的PTH病人比较,伴HT的PTC病人女性比例更高,年龄更小,病灶边界不清比例更高,甲状腺包膜受侵比例及中央区淋巴结转移发生率更低,差异有统计学意义(P<0.05)。多因素Logistic回归分析显示,低龄、肿瘤最大径大及甲状腺包膜受侵,发生中央区淋巴结转移的风险越大(OR值分别为0.940,1.644,0.434,P值分别为<0.001,0.027,0.012)。受试者工作特征(ROC)曲线分析显示,年龄39.5岁及肿瘤最大径0.525cm是伴HT的PTC病人中央区淋巴结转移危险因素截点。
结论  伴HT的PTC多见于年轻女性,其病灶边界不清,甲状腺包膜不易受侵,中央区淋巴结转移发生率更低。手术可行单侧甲状腺及峡部切除或甲状腺全切除,中央区淋巴结清扫可个体化处理,对于年龄小于39.5岁、肿瘤最大径大于0.525cm、甲状腺包膜受侵的病人建议常规行中央区淋巴结清扫。

关键词: 桥本甲状腺炎, 甲状腺乳头状癌, 临床病理特征, 危险因素, 外科手术

Abstract: Objective  To analyze the clinicopathological features and surgical strategy of papillary thyroid carcinoma(PTC) with coexistent Hashimoto’s thyroiditis(HT).
Methods  The clinical data of 884 patients with papillary thyroid cancer who underwent the first thyroid surgery in the same diagnosis and treatment group of General Surgery Department of Jiangsu Province Hospital of Chinese Medicine from July 2016 to December 2020 were analyzed retrospectively.The clinicopathological features of PTC patients with coexistent HT and PTC patients without HT were compared,and the risk fastors of central lymph node metastasis in PTC patients coexistent HT were analyzed.
Results  PTC patients with coexistent HT accounted for 30.8% of the total PTC patients.Compared with the PTC patients without HT,PTC patients with coexistent HT had higher proportion of females,younger age,higher proportion of unclear lesion boundary,lower proportion of thyroid capsule invasion and central lymph node metastasis(P<0.05).Multivariate logistic regression analysis showed that younger age,larger tumor diameter and thyroid capsule invasion were associated with higher risk of central lymph node metastasis(OR:0.940,1.644,0.434,P:<0.001,0.027,0.012,respectively).Receiver operating characteristic(ROC) curve analysis showed that age of 39.5 years and maximum tumor diameter of 0.525 cm were cut-off points for central lymph node metastasis in PTC patients with coexistent HT.
Conclusion  PTC with coexistent HT is more common in young women,with unclear boundary,less invasion of thyroid capsule and lower incidence of central lymph node metastasis.Unilateral thyroidectomy and isthmus resection or total thyroidectomy are feasible.Central lymph node dissection can be individualized.For patients younger than 39.5 years old,the maximum diameter of tumor greater than 0.525 cm and thyroid capsule invasion,central lymph node dissection should be routinely performed.

Key words: Hashimoto’s thyroiditis, papillary thyroid carcinoma, clinicopathological features, risk factors, surgical procedure

[1] 叶彬 向秋 金文杰. 叉头框蛋白Q1和细胞周期蛋白D1在非小细胞肺癌组织中的表达与临床病理特征及预后的关系[J]. 临床外科杂志, 2022, 30(5): 453-458.
[2] 达娃卓玛 王雨晨 刘士强 夏耘. 结节性硬化症合并甲状腺乳头状癌一例[J]. 临床外科杂志, 2022, 30(4): 391-392.
[3] 中国医师协会急救复苏专业委员会创伤骨科与多发伤学组 中国医药教育学会骨质疾病专业委员会修复重建学组 中国老年学和老年医学学会老年病分会骨科专家委员会 中华医学会骨科学分会青年骨质疏松学组/曹发奇 闫晨晨 薛航 苏佳灿 张英泽 刘国辉. 中国老年髋部骨折病人行微创手术治疗专家共识[J]. 临床外科杂志, 2022, 30(4): 394-400.
[4] 李铃睿 宋俊龙 刘汉卿 孔德光 陈创. 甲状腺乳头状癌的基因变异与临床病理特点分析[J]. 临床外科杂志, 2022, 30(3): 222-225.
[5] 顾青青 王建华 陈国芳 曹晨燕. 多发性内分泌腺瘤病1型二例[J]. 临床外科杂志, 2022, 30(3): 226-229.
[6] 张传灼 任明 孟达理 王平 王勇. 甲状腺髓样癌颈侧区淋巴结转移的危险因素分析[J]. 临床外科杂志, 2022, 30(3): 230-233.
[7] 向璇 吾甫尔·依马尔 王护国. 甲状腺切除术后甲状旁腺损伤相关危险因素Meta分[J]. 临床外科杂志, 2022, 30(3): 234-238.
[8] 李昕倩 陈创 孙圣荣. 手术与非手术治疗肉芽肿性小叶性乳腺炎疗效及复发因素分析[J]. 临床外科杂志, 2022, 30(2): 145-148.
[9] 赵硕 党诚学 李文星 刘嘉欣 杨刚华. 食管癌术后吻合口漏危险因素分析[J]. 临床外科杂志, 2022, 30(2): 161-164.
[10] 官艳 何林钰 罗茵. 肝内胆管结石病人肝切除术后感染性并发症风险预测模型的构建及验证[J]. 临床外科杂志, 2022, 30(2): 182-185.
[11] 穆静辉, 冯文静. 甲状腺乳头状癌伴发桥本甲状腺炎行甲状腺全切手术后生存质量分析[J]. 临床外科杂志, 2021, 29(8): 761-763.
[12] 周雷 丁胜义 王朝 陈磊. 甲状腺乳头状癌病人甲状腺全切术右侧喉返神经深层淋巴结转移情况分析[J]. 临床外科杂志, 2021, 29(7): 652-655.
[13] 李亮, 李小玲, 路霖等. 杂交手术与支架象鼻术治疗复杂性B型主动脉夹层的近中期疗效分析及并发症危险因素的Logistic回归分析[J]. 临床外科杂志, 2021, 29(6): 526-529.
[14] 王振军 胡子龙. 直肠癌的治疗进展和看法[J]. 临床外科杂志, 2021, 29(5): 409-411.
[15] 郑衍洪 梁柱 马炳太 黄厚沐. 左侧肺癌切除联合区域淋巴结清扫手术病人淋巴结转移与临床病理的关系分析[J]. 临床外科杂志, 2021, 29(5): 463-465.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 宫念樵. 器官捐献供肾质量评估[J]. 临床外科杂志, 2016, 24(10): 729 .
[2] 黄洪锋. 关注公民逝世后器官捐献肾移植受体围手术期感染的预防与处理[J]. 临床外科杂志, 2016, 24(10): 732 .
[3] 邱江. 心脏死亡捐献供肾移植免疫抑制方案的选择[J]. 临床外科杂志, 2016, 24(10): 735 .
[4] 林俊. 原发性中枢神经系统恶性肿瘤供者在器官移植中的应用[J]. 临床外科杂志, 2016, 24(10): 737 .
[5] 胡善彪;余少杰;彭龙开. 婴幼儿供肾移植[J]. 临床外科杂志, 2016, 24(10): 741 .
[6] 昌盛. 中国心脏死亡捐献供肾器官的维护[J]. 临床外科杂志, 2016, 24(10): 744 .
[7] 杨华;李新长;龙成美;等. 公民逝世后器官捐献供肾移植临床分析[J]. 临床外科杂志, 2016, 24(10): 747 .
[8] 石宇;刘学刚 . 冠状动脉旁路移植术后短期内应用强化他汀对患者出血风险的研究[J]. 临床外科杂志, 2016, 24(10): 750 .
[9] 陈忠;王耀东;田毅峰;等. 肝胆管结石病规范化治疗的临床分析[J]. 临床外科杂志, 2016, 24(10): 753 .
[10] 齐卫鹏;王剑明;刘颜;等. 术前应用靛氰绿检测联合三维重建成像评估肝门部胆管癌肝脏储备功能[J]. 临床外科杂志, 2016, 24(10): 756 .